|
Rivera-Caravaca JM, Viedma-Viedma I, Roldán V. Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients. Biol Res Nurs. 2017 Mar;19(2):198-205. doi: 10.1177/1099800416671211. Epub 2016 Sep 28. PubMed PMID: 27680769.
AÑO: 2017; IF: 1.579
|
27680769
|
García-Fernández A, Roldán V, Rivera-Caravaca JM, Lip GYH, Marín F. Applicability of the modified CHA(2)DS(2)-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. Eur J Intern Med. 2017 Mar;38:e21-e22. doi: 10.1016/j.ejim.2016.11.006. Epub 2016 Nov 15. PubMed PMID: 27863991.
AÑO: 2017; IF: 3.282
|
|
García-Fernández A, Roldán V, Rivera-Caravaca JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? Sci Rep. 2017 Jan 30;7:41565. doi: 10.1038/srep41565. PubMed PMID: 28134282; PubMed Central PMCID: PMC5278507.
AÑO: 2017; IF: 4.122
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost. 2017 Jun 27;117(7):1448-1454. doi: 10.1160/TH16-12-0961. Epub 2017 Mar 23. PubMed PMID: 28331926.
AÑO: 2017; IF: 6.681
|
|
Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Raña-Míguez P, Anguita M, Muñiz J, Cequier Á, Bertomeu-Martínez V, Valdés M, Vicente V, Lip GYH, Roldán V. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. Am J Cardiol. 2017 Dec 15;120(12):2176-2181. doi: 10.1016/j.amjcard.2017.09.003. Epub 2017 Sep 19. PubMed PMID: 29111209.
AÑO: 2017; IF: 3.171
|